AEOLUS PHARMACEUTICALS

Healthcare 📍 Mission Viejo, United States 👥 1001-5000 employees 💰 $18.5M raised 📅 Founded 1994

Aeolus Pharmaceuticals, Inc. is developing its lead compound, AEOL-10150, as a treatment for the pulmonary and delayed effects of acute radiation exposure (“Lung-ARS” and “DEARE”). The Company’s development work is funded under a five year, $118 million, cost-plus contract with the Biomedical Advanced Research and Dev

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1001-5000

Total Raised · Post-IPO

$18.5M

Founded

1994

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$11M – $27M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from AEOLUS PHARMACEUTICALS's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Peloton Interactive

1001-5000 ☁️ Vercel

1001-5000 ☁️ Unknown

1001-5000 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction